The rate of trachoma, or ocular chlamydia, among children living in hyperendemic areas can be stalled with annual or biannual mass azithromycin distribution. However, discontinuing the antibiotic after 4 years led to an increased rate of infection in the pediatric population, according to trial results published in PLoS Medicine.
“WHO recommends annual mass azithromycin administration in communities with at least 10% prevalence of trachomatous inflammation-follicular, or TF, in children, with further treatment depending on reassessment after 3 to 5 years,” Jeremy D. Keenan, MD, a
Uncategorized